// App-Quantinova.ai

4893 : Molecular detection of ALL in the peripheral blood is more sensitive than flow cytometric analysis of the bone marrow in patients with treatment-related hypocellularity

Researchers

Presenter

  • Hannah Smithers

Principal Investigators

  • Olivia Finney

  • Ilan Kirsch

  • Beryl Crossley

  • Michael Jensen

  • Rebecca Gardner

Medical Centers

  • Seattle Children's Research Institute, Seattle, WA

  • Adaptive Biotechnologies, Seattle, WA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Breakpoint Cluster Region

  • Cluster of Differentiation 19

  • Coxsackie Virus And Adenovirus Receptor

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A